Role of chemotherapy before allogeneic stem cell transplantation (allo-SCT) from an HLA-identical sibling donor for myelodysplastic syndrome (MDS).

被引：0
|
作者：
Nakai, K
Kanda, Y
Fukuhara, S
Sakamaki, H
Okamoto, S
Kodera, Y
Tanosaki, R
Takahashi, S
Matsushima, T
Atsuta, Y
Hamajima, N
Kasai, M
Kato, S
机构：
[1] Kansai Med Univ, Dept Internal Med 1, Osaka, Japan
[2] Tokyo Univ Hosp, Dept Cell Therapy & Transplantat Med, Tokyo 113, Japan
[3] Tokyo Metropolitan Komagome Hosp, Div Hematol, Tokyo, Japan
[4] Keio Univ, Sch Med, Div Hematol, Tokyo, Japan
[5] Nagoya First Hosp, Japanese Red Cross, Dept Internal Med, Nagoya, Aichi, Japan
[6] Natl Canc Ctr, Hematopoiet Stem Cell Transplantat Unit, Tokyo 104, Japan
[7] Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Tokyo, Japan
[8] Gunma Univ, Grad Sch med, Dept Med & Clin Sci, Gunma, Japan
[9] Nagoya Univ, Grad Sch Med, Dept Prevent Med Biostat & Med Decis Making, Nagoya, Aichi, Japan
[10] Sapporo Hokuyu Hosp, Dept Internal Med, Sapporo, Hokkaido, Japan
[11] Tokai Univ, Sch Med, Dept Cell Transplantat & Regenerat Med, Isehara, Kanagawa 25911, Japan
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5126
引用
收藏
页码：365B / 365B
页数：1
相关论文
共 50 条
  • [1] Value of chemotherapy before allogeneic hematopoietic stem cell transplantation from an HLA-identical sibling donor for myelodysplastic syndrome
    Nakai, K
    Kanda, Y
    Fukuhara, S
    Sakamaki, H
    Okamoto, S
    Kodera, Y
    Tanosaki, R
    Takahashi, S
    Matsushima, T
    Atsuta, Y
    Hamajima, N
    Kasai, M
    Kato, S
    LEUKEMIA, 2005, 19 (03) : 396 - 401
  • [2] Value of chemotherapy before allogeneic hematopoietic stem cell transplantation from an HLA-identical sibling donor for myelodysplastic syndrome
    K Nakai
    Y Kanda
    S Fukuhara
    H Sakamaki
    S Okamoto
    Y Kodera
    R Tanosaki
    S Takahashi
    T Matsushima
    Y Atsuta
    N Hamajima
    M Kasai
    S Kato
    Leukemia, 2005, 19 : 396 - 401
  • [3] SNPS IN THE PROMOTER REGION OF THE IL17A GENE ALLOW ANTICIPATION OF COMPLICATIONS AFTER SIBLING HLA-IDENTICAL ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT)
    Buces, E.
    Martinez-Laperche, C.
    Gonzalez-Rivera, M.
    Bosch-Vizcaya, A.
    Martin-Antonio, B.
    Guillem, V.
    Nieto, J.
    Gonzalez, M.
    de la Camara, R.
    Brunet, S.
    Espigado, I.
    Vallejo, C.
    Sampol, A.
    Serrano, D.
    Kwon, M.
    Gayoso, J.
    Balsalobre, P.
    Solano, C.
    Urbano-Izpizua, A.
    Jimenez-Velasco, A.
    Gallardo, D.
    Diez-Martin, J.
    Buno, I.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S75 - S75
  • [4] Long term infectious complications following reduced intensity conditioning (RIC)allogeneic HLA-identical sibling transplantation (allo-SCT).
    Etienne, Anne
    Mohty, Mohamad
    Faucher, Catherine
    Furst, Sabine
    El-Cheikh, Jean
    Zandotti, Christine
    Berger, Pierre
    Vey, Norbert
    Stoppa, Anne-Marie
    Bouabdallah, Reda
    Viens, Patrice
    Gastaut, Jean-Albert
    Blaise, Didier
    BLOOD, 2006, 108 (11) : 807A - 807A
  • [5] Long term infectious complications following reduced intensity conditioning (RIC) allogeneic HLA-identical sibling transplantation (allo-SCT)
    Etienne, A
    Mohty, M
    Faucher, C
    Ferrando, M
    Benramdane, R
    Zandotti, C
    Collet, L
    Vey, N
    Stoppa, AM
    Coso, D
    Viens, P
    Gastaut, JA
    Blaise, D
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 24 - 24
  • [6] Long term infectious complications following reduced intensity conditioning (RIC)allogeneic HLA-identical sibling transplantation (allo-SCT).
    Etienne, A
    Mohty, M
    Faucher, C
    Ferrando, M
    Benramdane, R
    Zandotti, C
    Collet, L
    Vey, N
    Stoppa, AM
    Coso, D
    Viens, P
    Gastaut, JA
    Blaise, D
    BLOOD, 2004, 104 (11) : 348A - 349A
  • [7] Allogeneic HLA-identical sibling transplantation (allo-SCT) with reduced intensity conditioning regimen for refractory lymphoid malignancies: a single center experience
    Bilger, K
    Faucher, C
    Mohty, M
    Vey, N
    Stoppa, AM
    Coso, D
    Chabannon, C
    Gastaut, JA
    Maraninchi, D
    Blaise, D
    BONE MARROW TRANSPLANTATION, 2003, 31 : S153 - S153
  • [8] Donor Selection for Allogeneic Stem Cell Transplantation In Elderly Patients with Advanced MDS: Younger Matched-Unrelated Donor or HLA-Identical Sibling ?
    Kroger, Nicolaus
    Zabelina, Tatjana
    van Biezen, Anja
    Zander, Axel R.
    de Witte, Theo
    BLOOD, 2010, 116 (21) : 402 - 403
  • [9] Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantation
    G A Kennedy
    J Butler
    R Western
    J Morton
    G Hill
    S Durrant
    Leukemia, 2005, 19 : 317 - 318
  • [10] Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantation
    Gallardo, D
    De la Cámara, R
    Torres, A
    Brunet, S
    Jiménez, A
    Vallejo, JC
    Sanz, G
    Serrano, D
    Carreras, E
    Martín, C
    Sanz-Rodríguez, C
    Sierra, J
    Espigado, I
    Caballero, D
    Berlanga, JJ
    LEUKEMIA, 2004, 18 (05) : 1031 - 1034
12345